Hydrochloric Acid

Hydrochloric Acid

SCHEMBL19549166

Cl.Cl.Nc1cnn(CCO)c1N

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KIT known ✓ P10721 1/20 0.32
CYP1A2 P05177 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.32
MAPT P10636 1/20 0.31
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6030708 1.00 CYP1A2 (0.41) CYP1A2SMN1; SMN2KITMAPTTSHR
SCHEMBL33881 0.98 CYP1A2 (0.42) CYP1A2SMN1; SMN2KITMAPTTSHR
Bromide SCHEMBL26106807 0.96 CYP1A2 (0.41) CYP1A2SMN1; SMN2KITMAPTTSHR
Sulfuric Acid SCHEMBL143344 0.89 CYP1A2 (0.36) CYP1A2
Sulfuric Acid SCHEMBL2854050 0.89 CYP1A2 (0.36) CYP1A2
SCHEMBL3952062 0.89 CYP1A2 (0.36) CYP1A2TSHR
Sulfuric Acid SCHEMBL8919999 0.87 CYP1A2 (0.35) CYP1A2SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL6757419 0.87 TSHR (0.33) TSHR
SCHEMBL5398725 0.86 ADORA2A (0.33) CYP1A2
SCHEMBL2923881 0.84 TSHR (0.34) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3634365-B1 HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE HENKEL AG & CO KGAA (DE) 2022-08-10 EP claimed
EP-3496818-B1 PROCESS FOR PREPARING HAIR DYE AGENTS HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES HENKEL AG & CO KGAA (DE) 2021-01-20 EP claimed
US-10736827-B2 Hair dye agent having unilamellar and multilamellar vesicles HENKEL AG & CO. KGAA (DE) 2020-08-11 US claimed
US-20200170904-A1 HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE HENKEL AG & CO. KGAA (DE) 2020-06-04 US claimed
EP-3634365-A1 HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE Henkel AG & Co. KGaA (DE) 2020-04-15 EP claimed
EP-3496818-A1 HAIR DYE AGENT HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES Henkel AG & Co. KGaA (DE) 2019-06-19 EP claimed
US-20190175459-A1 HAIR DYE AGENT HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES HENKEL AG & CO. KGAA (DE) 2019-06-13 US claimed
WO-2018224244-A1 HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE HENKEL AG & CO. KGAA (DE) 2018-12-13 WO claimed
WO-2018028861-A1 HAIR DYE AGENT HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES HENKEL AG & CO. KGAA (DE) 2018-02-15 WO claimed
EP-3634365-B1 HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE HENKEL AG & CO KGAA (DE) 2022-08-10 EP disclosed
EP-3496818-B1 PROCESS FOR PREPARING HAIR DYE AGENTS HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES HENKEL AG & CO KGAA (DE) 2021-01-20 EP disclosed
US-10736827-B2 Hair dye agent having unilamellar and multilamellar vesicles HENKEL AG & CO. KGAA (DE) 2020-08-11 US disclosed
US-10702459-B2 Hair dye having improved viscosity stability HENKEL AG & CO. KGAA (DE) 2020-07-07 US disclosed
US-20200170904-A1 HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE HENKEL AG & CO. KGAA (DE) 2020-06-04 US disclosed
US-10357436-B2 Solid-stabilized oxidizing agent preparation, product and kit for oxidatively changing the color of hair HENKEL AG & CO. KGAA (DE) 2019-07-23 US disclosed
EP-3496818-A1 HAIR DYE AGENT HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES Henkel AG & Co. KGaA (DE) 2019-06-19 EP disclosed
US-20190175459-A1 HAIR DYE AGENT HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES HENKEL AG & CO. KGAA (DE) 2019-06-13 US disclosed
US-20190083372-A1 HAIR DYE HAVING IMPROVED VISCOSITY STABILITY HENKEL AG & CO. KGAA (DE) 2019-03-21 US disclosed
WO-2018028861-A1 HAIR DYE AGENT HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES HENKEL AG & CO. KGAA (DE) 2018-02-15 WO disclosed
US-20170319442-A1 SOLID-STABILIZED OXIDIZING AGENT PREPARATION, PRODUCT AND KIT FOR OXIDATIVELY CHANGING THE COLOR OF HAIR HENKEL AG & CO. KGAA (DE) 2017-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190083372-A1 HAIR DYE HAVING IMPROVED VISCOSITY STABILITY KRT18, S100B, SHH KIT 1173/4885CYP1A2 2761/4885SMN1; SMN2 2196/4885
US-10357436-B2 Solid-stabilized oxidizing agent preparation, product and kit for oxidatively changing the color of hair GPX4, MPO, GPX1 KIT 162/4885CYP1A2 987/4885SMN1; SMN2 3373/4885
US-20170319442-A1 SOLID-STABILIZED OXIDIZING AGENT PREPARATION, PRODUCT AND KIT FOR OXIDATIVELY CHANGING THE COLOR OF HAIR GPX4, MPO, GPX1 KIT 162/4885CYP1A2 987/4885SMN1; SMN2 3373/4885
US-10736827-B2 Hair dye agent having unilamellar and multilamellar vesicles EXOSC10, ANXA5, ANXA4 KIT 2467/4885CYP1A2 2777/4885SMN1; SMN2 4337/4885
US-20200170904-A1 HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE UGCG, ADH1C, ELOVL1 KIT 3491/4885CYP1A2 1162/4885SMN1; SMN2 3053/4885
US-10702459-B2 Hair dye having improved viscosity stability KRT18, S100B, SHH KIT 1189/4885CYP1A2 2719/4885SMN1; SMN2 2183/4885
US-20190175459-A1 HAIR DYE AGENT HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES EXOSC10, ANXA5, ANXA4 KIT 2467/4885CYP1A2 2777/4885SMN1; SMN2 4337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.